Ind-Swift Ltd.
₹15.76+6.13%Aug 27, 4:00 AM IST
INDSWFTLTD•Health Technology•Pharmaceuticals: Major
Current Price
₹15.76+6.13%
Aug 27, 4:00 AM ISTMarket Cap₹85.04 Cr
Market Cap₹85.04 Cr
Business Overview
Ind-Swift Limited operates through 1 main business divisions including Pharmaceutical Products.
Business Hierarchy Structure for Ind-Swift Limited
- Ind-Swift Limited
- Pharmaceutical Products
- Global Business Unit (ISL-GBU)
- Developed Markets Focus
- UK
- European Union
- Australia
- Canada
- Brazil
- South Africa
- Semi-Regulated Markets Focus
- Africa
- Southeast Asia
- Latin America
- CIS Countries
- MENA Region
- Product Development Focus
- Non-infringing generic products for USA, EU, TGA, Canada
- Formulation Types
- IR (Immediate Release)
- MR (Modified Release)
- GR/DR (Granules/Delayed Release)
- MUPS (Multiple-Unit Pellet Systems)
- Coated Granules
- Fixed-Dose Combination (FDC) products
- Developed Markets Focus
- Domestic Operations
- Ethical Division
- Gynaecology Segment
- Paediatrics Segment
- Dermatology Segment
- Nova Division
- Anti-infective Therapies
- Cardio-diabetic Therapies
- Orthopedic Therapies
- Generic Division
- Chronic Segment Focus
- Cardiac
- Diabetic
- Neuropsychiatry
- Products
- Metalazone
- Lenalidomide Anhydrous
- Methotrexate
- Chronic Segment Focus
- Ethical Division
- Global Business Unit (ISL-GBU)
- Pharmaceutical Products